CBIO 8-K 2026-10-15

CRESCENT BIOPHARMA, INC. (CBIO) 8-K dated 2026-10-15 — accession 0001628280-26-066006. This URL is the filing, not the CBIO hub.

CRESCENT BIOPHARMA, INC. (CBIO) is a biotechnology company listed on NASDAQ.

CRESCENT BIOPHARMA, INC. filed a 8-K on 2026-10-15. Accession 0001628280-26-066006.

Cached items: 8.01. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported CBIO revenue for 2025-12-31 was $10.8M. Net income was -$153.9M. CBIO currently screens at market cap $491.3M.

Not investment advice. The CBIO SEC hub lists recent forms. The stock page is the research view.